Why Moderna Could Be Worth $100 Billion Within 5 Years

Why Moderna Could Be Worth $100 Billion Within 5 Years

There are only a dozen drugmakers in the world right now with market caps of $100 billion or more. At least, that's what Oppenheimer analyst Hartaj Singh thinks. The most important factor by far behind Singh's bullish view on Moderna is the company's COVID-19 vaccine, mRNA-1273.